Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
However, some patients experience unexpected weight gain or fail to lose weight whilst taking this medication
Clinical trial data from the Phase 2 studies showed participants losing an average of 24.2% of their body weight over 48 weeks at the highest dose
The differences observed can be attributed to several factors inherent to real-world studies as compared to RCTs, and future work is needed to further characterize patient profiles most likely to benefit from GLP-1s with findings from both structured and unstructured clinical data modalities
Burtle, G
2024;187(14):360218 e20
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
